Burning Rock Biotech Limited
BNR
$4.52
-$0.18-3.83%
| 03/31/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.64% | 24.64% | 7.01% | 7.01% | -28.99% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.95% | 25.95% | -48.92% | -48.92% | 137.16% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -152.44% | -152.44% | 66.11% | 66.11% | 42.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -131.19% | -131.19% | 488.65% | 488.65% | 34.41% |
| Cash from Investing | -631.94% | -631.94% | 83.44% | 83.44% | 34.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 111.04% | 111.04% | -4,475.07% |
| Cash from Financing | -- | -- | 95.83% | 95.83% | -4,327.39% |
| Foreign Exchange rate Adjustments | 101.63% | 101.63% | -165.28% | -165.28% | -109.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.69% | -98.69% | 77.62% | 77.62% | -33.67% |
